Wordt geladen...
Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990–2013
BACKGROUND: 23-Valent pneumococcal polysaccharide vaccine, trade name Pneumovax(®)23 (PPSV23), has been used for decades in the Unites States and has an extensive clinical record. However, limited post-licensure safety assessment has been conducted. OBJECTIVE: To analyze reports submitted to the Vac...
Bewaard in:
| Gepubliceerd in: | Vaccine |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6546117/ https://ncbi.nlm.nih.gov/pubmed/27087150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.04.021 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|